A cohort study to determine factors associated with upstaging cutaneous squamous cell carcinoma during Mohs surgery - 14/12/22
Doi : 10.1016/j.jaad.2022.03.055
Theresa N. Canavan, MD, Arda B. Celen, BA, MSc, Nicholas J. Frazzette, MS, John A. Carucci, MD, PhD, Nicole Doudican, PhD, Mary L. Stevenson, MD ⁎ 
Ronald O. Perelman Department of Dermatology, New York University Langone Medical Center, New York
∗Correspondence to: Mary L. Stevenson, MD, Ronald O. Perelman Department of Dermatology, New York University Langone Medical Center, Ambulatory Care Center, 222 E 41st Street, Floor 24, New York, NY 10017Ronald O. Perelman Department of DermatologyNew York University Langone Medical CenterAmbulatory Care Center222 E 41st StreetFloor 24New YorkNY10017
Key words : cutaneous squamous cell carcinoma, dermatopathology, high-risk cancer features, immunosuppression, Mohs micrographic surgery, upstaging
| Dr Canavan and Author Celen contributed equally to this article. |
|
| Funding sources: Supported by a Dermatology Foundation, Career Development Award in Dermatologic Surgery (to Mary L. Stevenson, MD). |
|
| IRB approval status: Reviewed and approved by NYU i18-01209: Outcomes of Primary Cutaneous SCC. |
|
| Reprints not available from the authors. |
© 2022
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 88 - N° 1
P. 191-194 - janvier 2023 Retour au numéro
Article précédent
- Preliminary definition of cutaneous flare in dermatomyositis: A retrospective review
- Joshua Dan, Mohsen Afarideh, Grant Sprow, Emily Keyes, DeAnna Diaz, Thomas Vazquez, Nilesh Kodali, Victoria P. Werth
- Association between state-specific reimbursement and Medicaid acceptance for Mohs micrographic surgery
- Eric J. Beltrami, Jette Hooper, Vijay Kodumudi, Christian Gronbeck, Hao Feng
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?